131 related articles for article (PubMed ID: 3385913)
1. Platelet aggregation and thromboxane B2 release in patients with acute myocardial infarction--their relation to coronary patency.
Takatsu Y; Yui Y; Hattori R; Sakaguchi K; Susawa T; Yui N; Takahashi M; Aoyama T; Tamaki S; Kawai C
Jpn Circ J; 1988 Apr; 52(4):314-20. PubMed ID: 3385913
[TBL] [Abstract][Full Text] [Related]
2. [Thrombocyte aggregation and serum thromboxane in patients with acute myocardial infarction].
Midttun M; Grauholt AM; Grande P
Ugeskr Laeger; 1990 Dec; 153(1):25-6. PubMed ID: 2275044
[TBL] [Abstract][Full Text] [Related]
3. [Platelet activation during thrombolysis and percutaneous transluminal coronary angioplasty in the acute phase of myocardial infarction].
Abe S; Maruyama I; Arima S; Yamaguchi H; Okino H; Hamasaki S; Nomoto K; Atsuchi Y; Tahara M; Tanaka H
J Cardiol; 1990; 20(4):849-59. PubMed ID: 2151948
[TBL] [Abstract][Full Text] [Related]
4. Whole blood aggregation, thromboxane release and the lyso derivative of platelet activating factor in myocardial infarction and unstable angina.
Nidorf SM; Sturm M; Strophair J; Kendrew PJ; Taylor RR
Cardiovasc Res; 1989 Apr; 23(4):273-8. PubMed ID: 2590911
[TBL] [Abstract][Full Text] [Related]
5. Platelet hyperactivity in acute myocardial infarction in man--effects of prostacyclin.
Mueller HS; Rao PS; Greenberg MA; Buttrick PM; Sussman II; Levite HA; Grose RM; Perez-Davila V; Strain JE; Spaet TH
Herz; 1986 Apr; 11(2):116-26. PubMed ID: 2939012
[TBL] [Abstract][Full Text] [Related]
6. Platelet function abnormalities in response to arachidonic acid in the acute phase of myocardial infarction.
McDaniel HG; Maddox WT; Poon MC; Rogers WJ; Rackley CE
Am J Cardiol; 1983 Nov; 52(8):965-8. PubMed ID: 6416046
[TBL] [Abstract][Full Text] [Related]
7. Systemic and transcardiac platelet activity in acute myocardial infarction in man: resistance to prostacyclin.
Mueller HS; Rao PS; Greenberg MA; Buttrick PM; Sussman II; Levite HA; Grose RM; Perez-Davila V; Strain JE; Spaet TH
Circulation; 1985 Dec; 72(6):1336-45. PubMed ID: 2933181
[TBL] [Abstract][Full Text] [Related]
8. [Effects of adenosine on blood prostaglandin level and platelet aggregation in experimental myocardial infarct].
Almazov VA; Gurevich VS; Eliseev VV; Krylova IB; Skholl'-Engberts AD; Poltavchenko GM
Biull Eksp Biol Med; 1991 Jul; 112(7):37-8. PubMed ID: 1793847
[No Abstract] [Full Text] [Related]
9. Increased platelet aggregation and serum thromboxane levels in aspirin-treated patients with prior myocardial infarction.
Larsen SB; Neergaard-Petersen S; Grove EL; Kristensen SD; Hvas AM
Thromb Haemost; 2012 Jul; 108(1):140-7. PubMed ID: 22534977
[TBL] [Abstract][Full Text] [Related]
10. Determinants of reduced antiplatelet effect of aspirin in patients with stable coronary artery disease.
Larsen SB; Grove EL; Neergaard-Petersen S; Würtz M; Hvas AM; Kristensen SD
PLoS One; 2015; 10(5):e0126767. PubMed ID: 25993271
[TBL] [Abstract][Full Text] [Related]
11. [Effect of molsidomine infusion on thrombocyte function in acute myocardial infarct].
Hiller E; Fischer U; von Essen R; Riess H
Z Kardiol; 1991; 80 Suppl 5():59-62. PubMed ID: 1837969
[TBL] [Abstract][Full Text] [Related]
12. Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction.
Fitzgerald DJ; Catella F; Roy L; FitzGerald GA
Circulation; 1988 Jan; 77(1):142-50. PubMed ID: 3275505
[TBL] [Abstract][Full Text] [Related]
13. Thromboxane A2 in acute myocardial infarction.
Walinsky P; Smith JB; Lefer AM; Lebenthal M; Urban P; Greenspon A; Goldberg S
Am Heart J; 1984 Oct; 108(4 Pt 1):868-72. PubMed ID: 6485997
[TBL] [Abstract][Full Text] [Related]
14. Individual variation in platelet aggregability and serum thromboxane B2 concentrations after low-dose aspirin.
Tohgi H; Tamura K; Kimura B; Kimura M; Suzuki H
Stroke; 1988 Jun; 19(6):700-3. PubMed ID: 3376161
[TBL] [Abstract][Full Text] [Related]
15. Association of patency of the infarct-related coronary artery with plasma levels of plasminogen activator inhibitor activity in acute myocardial infarction.
Sakamoto T; Yasue H; Ogawa H; Misumi I; Masuda T
Am J Cardiol; 1992 Aug; 70(3):271-6. PubMed ID: 1632387
[TBL] [Abstract][Full Text] [Related]
16. Randomized trial of ridogrel, a combined thromboxane A2 synthase inhibitor and thromboxane A2/prostaglandin endoperoxide receptor antagonist, versus aspirin as adjunct to thrombolysis in patients with acute myocardial infarction. The Ridogrel Versus Aspirin Patency Trial (RAPT).
Circulation; 1994 Feb; 89(2):588-95. PubMed ID: 8313547
[TBL] [Abstract][Full Text] [Related]
17. Aspirin reload before elective percutaneous coronary intervention: impact on serum thromboxane b2 and myocardial reperfusion indexes.
Basili S; Tanzilli G; Raparelli V; Calvieri C; Pignatelli P; Carnevale R; Dominici M; Placanica A; Arrivi A; Farcomeni A; Barillà F; Mangieri E; Violi F
Circ Cardiovasc Interv; 2014 Aug; 7(4):577-84. PubMed ID: 25074252
[TBL] [Abstract][Full Text] [Related]
18. Combined arachidonic acid and ADP platelet inhibition maximizes patency of small-diameter vascular grafts.
Valentin LI; Sicard GA; Freeman MB; Allen BT; McGoff MA; Anderson CB
Surgery; 1988 Aug; 104(2):178-84. PubMed ID: 3135624
[TBL] [Abstract][Full Text] [Related]
19. [Antiaggregant effect and tolerance of calcium carbasalate administrated immediately after aorto-coronary bypass. Results of a double-blind versus placebo study].
Mathieu P; Villemot JP; Stoltz JF; Scheck F; Garnier LF
Pathol Biol (Paris); 1996 Jun; 44(6):571-80. PubMed ID: 8977914
[TBL] [Abstract][Full Text] [Related]
20. Oxygen radical scavenging agents as adjuvant therapy with tissue plasminogen activator in a canine model of coronary thrombolysis.
Przyklenk K; Kloner RA
Cardiovasc Res; 1993 Jun; 27(6):925-34. PubMed ID: 8221780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
